Here are the top stories covered by DocWire News this week in the Hematology & Oncology section. This week, a study identified six foods and nutrients that either increase or decrease the risk of breast cancer, a report found that enrollment in cancer clinical trials is low, and more.
A study published in Breast Cancer Research identified six foods and nutrients that are associated with breast cancer incidence.
A recent study published in JAMA corroborated a statement from the U.S. Food and Drug Administration last year that found active ingredients in sunscreen can be absorbed into the bloodstream.
A study published in Nature Cancer identified nearly 50 already-developed drug compounds that have anti-cancer potential, including therapies for diabetes, inflammation, and alcoholism.
Adults taking opioids to control cancer-related pain did not find any additional benefit by adding cannabinoids to their routine when compared to placebo, new research has found.
According to the findings of a study published in the Journal of the National Comprehensive Cancer Network enrollment in life-extending clinical trials for cancer treatment is low, except among white males with private insurance.
In case you missed it, more hem/onc headlines are featured below:
- Novel Agent Tislelizumab Extends Survival in Lung Cancer: Interim Phase III Report
- Ringing the Ceremonial “Cancer Bell” Following Course of Treatment May Have Unintended Consequences on Patients
- Study Compares Out-of-pocket Costs for Robotic versus Open Surgery for Cancer
- Here Are The Possible Five-year Effects Associated with Five Treatments for Localized Prostate Cancer
- New Technique Accurately Predicts Which Melanoma Patients Face an Increased Risk of Recurrence, Spread